N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors

摘要

The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R, R, R and R are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl- CoA carboxylase enzyme(s) in an animal.